Advanced Enzyme Technologies Limited — Board Meeting, 02-08-2025: Outcome of Board Meeting
02-08-2025 | 12:57 pm
02-08-2025 | 12:57 pm
Advanced Enzyme Technologies' board has approved key decisions for retail investors. The company reported strong consolidated financial results for the quarter ended June 30, 2025, with Revenue from operations at Rs 185.91 Cr and Net Profit at Rs 40.44 Cr. Additionally, the board approved an investment of Rs 1 Cr in Advanced Nutrazyme Private Limited, a newly incorporated wholly-owned subsidiary. This new entity will focus on sales and distribution of the company's Nutrition and Wellness products, signaling a strategic focus on expanding market reach in this segment.
No comments yet. Be the first to comment!
